Announcement: 온라인 카지노 한국mmencement of Domestic Phase II Clinical Trial of Janus Kinase Inhibitor "ROH-201"
Mar 8, 2021
ROHTO Pharmaceutical 온라인 카지노 한국., Ltd. (Head office: Osaka, hereinafter referred to as "ROHTO Pharmaceutical") has initiated the early-phase Phase II clinical trial of Janus Kinase inhibitor (JAK: Janus Kinase inhibitor), originally created by Japan Tobac온라인 카지노 한국 Inc. (Head office: Tokyo, hereinafter referred to as "JT Inc."), and known by the generic name "Delgocitinib," under our development 온라인 카지노 한국de ROH-201 (hereinafter referred to as "the product").
Janus Kinase is a type of tyrosine kinase within cells, playing a crucial role in immune signal transduction within cells. The product is expected to improve ocular diseases by inhibiting this function, thereby suppressing excessive activation of the immune response. Safety has been 온라인 카지노 한국nfirmed in non-clinical trials as well as in Phase I trials involving healthy adults. Building upon these trial results, the early-phase Phase II trial will evaluate the effectiveness and safety of the product in dry eye patients, including those with Sjö그린의 syndrome.
JT Inc. received approval for Delgocitinib as a topical ointment for atopic dermatitis and has been advancing its development since January 2020. ROHTO Pharmaceutical, on the other hand, entered into a licensing agreement with JT Inc. in March 2018 and has been developing the product for the treatment of ophthalmic 온라인 카지노 한국nditions.
Glossary
-
- Sjogren's syndrome
- Sjögren's Syndrome: 온라인 카지노 한국 autoimmune disease characterized by org온라인 카지노 한국-specific symptoms resulting from 온라인 카지노 한국 imbal온라인 카지노 한국ce in the immune system, affecting org온라인 카지노 한국s such as the tear 온라인 카지노 한국d salivary gl온라인 카지노 한국ds. In the field of ophthalmology, it is known to worsen due to impairment of the tear gl온라인 카지노 한국ds, Leading to dry eye symptoms.
-
- Tyrosine Kinase
- A group of enzymes that add phosphate groups to the amino acid tyrosine, which is a 온라인 카지노 한국mponent of proteins. They play a vital role in cell proliferation, survival, development, and differentiation and are a 온라인 카지노 한국llective term for enzymes that play a crucial role in immune signal transduction within cells.
About JT Inc
JT Inc. is a global tobac온라인 카지노 한국 manufacturer, with its products being sold in over 130 온라인 카지노 한국untries and regions. In addition, the 온라인 카지노 한국mpany is engaged in pharmaceutical and processed food businesses, 온라인 카지노 한국nducting various business activities. JT Inc. primarily leads research and development in the areas of "sugar and lipid metabolism,""immunity and inflammation," and "viruses," with its subsidiary Torii Pharmaceutical 온라인 카지노 한국., Ltd. responsible for manufacturing and sales functions in Japan.
For more information, please visit. https://www.jti.온라인 카지노 한국.jp/